Fund Overview
First Trust NYSE Arca Biotechnology ETF (FBT.TO) is an exchange-traded fund. Total net assets stand at CA$6.05M. The fund is issued by FT Portfolios Canada Co. It has been trading since October 29, 2014.
First Trust NYSE Arca Biotech ETF alone accounts for 99.95% of the portfolio.
Performance Analysis
The most recent close on file for FBT.TO is CA$47.43, dated September 4, 2026. The trailing one-year price return is +56.02%. Measured over 5 years, that is +11.29% a year compounded.
So far in 2026 the price is +30.95%. Across the complete calendar years on file, 2025 returned +21.02% and 2022 returned −0.19%. Of the 7 complete calendar years on file, 5 finished higher.
Price & Risk Profile
Daily returns over the trailing 8 years annualize to a volatility of 22.91%. Beta against the wider market is reported at 1.22. Over the past 52 weeks the price has ranged from CA$30.44 to CA$47.80. The latest close sits 55.81% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.